Exilite

K150051 · BTL Industries, Inc. · ONF · Apr 8, 2015 · General, Plastic Surgery

Device Facts

• Record ID: K150051
• Device Name: Exilite
• Applicant: BTL Industries, Inc.
• Product Code: ONF · General, Plastic Surgery
• Decision Date: Apr 8, 2015
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

Exilite system (inclusive of the handpiece used to deliver pulsed-light energy) is indicated for use in surgical and aesthetic applications in reduction of pigmented lesions, acne therapy, freckle, vascular lesions, facial blemish removal, and permanent reduction in hair regrowth, defined as a long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of treatment regimen.

Device Story

Exilite is an Intense Pulsed Light (IPL) system for dermatologic applications. It utilizes a flash lamp to emit a wide spectrum of light (480–1200nm). The system comprises a control unit with an 8.4" color touch screen and a handpiece featuring sapphire crystal for continuous contact cooling. Operators (clinicians) use the touch screen to set therapeutic parameters (fluence, pulse duration/delay) and monitor therapy. The handpiece includes a trigger button for application control. The device delivers pulsed-light energy to the skin to treat lesions or reduce hair regrowth. By providing controlled light energy, the device enables targeted dermatologic procedures, potentially benefiting patients through improved skin appearance and long-term hair reduction.

Clinical Evidence

No clinical data. Substantial equivalence is demonstrated through bench testing and comparison of technical characteristics. The device conforms to IEC 60601-1, IEC 60601-1-2, ISO 10993-5, ISO 10993-10, ISO 14971, and IEC 62304 standards.

Technological Characteristics

IPL system; flash lamp source; 480–1200nm wavelength; 10-60J/cm² fluence; sapphire crystal contact cooling; 8.4" color touch screen interface; Class II, BF electrical protection; 100-240V power. Standards: IEC 60601-1, IEC 60601-1-2, ISO 10993-5, ISO 10993-10, ISO 14971, IEC 62304.

Indications for Use

Indicated for patients requiring surgical and aesthetic dermatologic treatment, including reduction of pigmented lesions, acne therapy, freckle, vascular lesions, facial blemish removal, and permanent hair reduction.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• Intense Pulsed Light (IPL) Systems - Beijing KES Biology Technology Co., Ltd (K122995)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around it. Inside the circle is a stylized image of three human profiles facing right, with flowing lines that resemble ribbons or waves.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 8, 2015

BTL Industries Incorporated Mr. Jan Zarsky Executive Vice President 47 Loring Drive Framingham, Massachusetts 01702

Re: K150051 Trade/Device Name: Exilite Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: ONF Dated: January 6, 2015 Received: January 12, 2015

Dear Mr. Zarsky:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

{1}------------------------------------------------

device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Jennifer R. Stevenson -S

For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

#### Indications for Use

510(k) Number (if known) K150051

Device Name Exilite

Indications for Use (Describe)

Exilite system (inclusive of the handpiece used to deliver pulsed-light energy) is indicated for use in surgical and aesthetic applications in reduction of pigmented lesions, acne therapy, freckle, vascular lesions, facial blemish removal, and permanent reduction in hair regrowth, defined as a long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of treatment regimen.

| Type of Use (Select one or both, as applicable) | |
|---------------------------------------------------------------------|---------------------------------------------------------------------|
| <div> <span> <span style="font-size: 10pt;"> </span> </span> </div> | <div> <span> <span style="font-size: 10pt;"> </span> </span> </div> |
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows a logo for BTL. The logo consists of three blue diamonds that are interlocked. The letters B, T, and L are written inside each of the diamonds, respectively.

## Section 5 - 510(k) Summary

#### General Information

| Sponsor: | BTL Industries, Inc.<br>47 Loring Drive<br>Framingham, MA 01702<br>Tel: [phone]<br>Fax: [phone] |
|-----------------|-----------------------------------------------------------------------------------------------------------------|
| Applicant: | BTL Industries, Inc.<br>47 Loring Drive<br>Framingham, MA 01702<br>Tel: [phone]<br>Fax: [phone] |
| Contact Person: | Jan Zarsky<br>BTL Industries, Inc.<br>Executive VP |

[e-mail]

ONF

Summary Preparation 6 January 2015 Date:

#### Device Names

Product Code:

| Trade/Proprietary Name: | Exilite |
|------------------------------|--------------------------------------------------------------------------|
| Common Name: | Intense Pulsed Light (IPL) |
| Primary Classification Name: | Powered Light Based Non-Laser Surgical Instrument<br>With Thermal Effect |
| Classification Regulation: | 878.4810 |

#### Legally Marketed Predicate Devices

The Exilite system is an Intense Pulsed Light (IPL) system, and is substantially equivalent to the current product which is already cleared for USA distribution under the following 510(k) Premarket Notification number:

- . Intense Pulsed Light (IPL) Systems - Beijing KES Biology Technology Co., Ltd (K122995)

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows a logo and the words "Product Description" in bold font. The logo consists of three blue diamond shapes that are connected to each other. The letters "BTL" are inside the first diamond shape.

The Exilite device is indicated for the primary treatment of dermatologic deficiencies. It is Intense Pulsed Light System which uses a wide spectrum of light from 480 to 1200nm (yellow, green, red and infrared light).

The control unit of the device is fitted with a color touch screen, which significantly facilitates the use of the device. The on-screen information will guide you through the entire therapy by means of easy setting of parameters using touch-screen buttons and knobs/keys on the device. For easier control, the handpiece is equipped with trigger button, enabling to start the application instead of footswitch.

Any therapeutic parameter can be set easily by simple use of the touch-screen buttons. During the entire therapy time the device informs you about the chosen therapy and applied filter, the set fluence and other necessary data.

The Exilite consists of the following main components:

- . control unit
- user interface with 8.4" color touch screen .
- . handpiece with cooling sapphire crystal and trigger button

#### Indications for Use

Exilite system (inclusive of the handpiece used to deliver pulsed-light energy) is indicated for use in surgical and aesthetic applications in reduction of pigmented lesions, acne therapy, freckle, vascular lesions, facial blemish removal and permanent reduction in hair regrowth, defined as a long-term, stable reduction in the number of hairs re-growing when measured at 6, 9, and 12 months after the completion of treatment regimen.

#### Non-clinical Testing

The Exilite device has been thoroughly evaluated for electrical safety. The Exilite has been found to conform with applicable medical device safety standards. The system complies with the following standards:

ISO 14971 - Medical devices - Application of risk management to medical devices IEC 62304 - Medical Device Software - Software Life Cycle Processes

Medical Electrical Equipment

- General requirements for safety ISO 60601-1
- ISO 60601-1-2 Electromagnetic compatibility-Requirements and Tests
- Biological Evaluation of Medical Devices—Tests for In Vitro toxicity ISO 10993-5

ISO 10993-10 Biological Evaluation of Medical Devices-Test for Irritation and Skin Sensitization

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image shows the logo for BTL Clinical Testing. The logo consists of three blue diamond shapes, each containing a letter: B, T, and L. Below the logo, the words "Clinical testing" are written in a bold, sans-serif font.

The substantial equivalence determination for the Exilite system is not based upon clinical performance testing. The device safety and efficacy was demonstrated by comparison of technical characteristics between the Exilite as compared to the predicate devices.

### Comparison with the Predicate Device

| Device name | Exilite | Intense Pulsed light<br>(IPL) Systems |
|----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | BTL Industries Ltd. | Beijing KES Biology<br>Technology Co., Ltd. |
| 510(k)<br>number | Current submission | K122995 |
| Light Source | Intense Pulsed Light | Intense Pulsed Light |
| Emitted by | Flash lamp | Flash lamp |
| Operating<br>Conditions | Ambient temperature<br>+15 °C to +30 °C | N/A |
| | Relative humidity 30% to<br>75% | N/A |
| | Atmospheric pressure<br>700hPa to 1060hPa | N/A |
| | Position on castors | N/A |
| Operation | Touch screen | Touch screen |
| Wavelength | 480 – 1200 nm | 430 – 1200 nm |
| Deliver<br>System | Sapphire | Sapphire |
| Indications<br>for Use | Exilite system (inclusive of<br>the handpiece used to<br>deliver pulsed-light energy)<br>is indicated for use in<br>surgical and aesthetic<br>applications in reduction of<br>pigmented lesions, acne<br>therapy, freckle, vascular<br>lesions, facial blemish<br>removal and permanent<br>reduction in hair regrowth,<br>defined as a long-term,<br>stable reduction in the<br>number of hairs re-growing<br>when measured at 6, 9, and<br>12 months after the<br>completion of treatment<br>regimen. | The Intense Pulsed<br>Light (IPL) Systems<br>(inclusive of the<br>handpiece used to<br>deliver pulsed-light<br>energy)<br>are indicated for use in<br>surgical, aesthetic and<br>cosmetic applications in<br>permanent hair<br>removal, skin<br>rejuvenation, reduction<br>of pigmented lesions,<br>acne therapy, freckle,<br>vascular lesions and<br>facial blemish removal. |
| Device name | Exilite | Intense Pulsed light<br>(IPL) Systems |
| Manufacturer | BTL Industries Ltd. | Beijing KES Biology<br>Technology Co., Ltd. |
| 510(k)<br>number | Current submission | K122995 |
| Electrical<br>Protection | Class II, BF | Class II, BF |
| Maximal<br>Fluence | 10-60J/cm² | 10-60J/cm² |
| Spot Size | 11x40mm | 12x33mm<br>15x50mm<br>15x35mm |
| Pulse Delay | 1-50ms | 5-50 ms |
| Pulse<br>Duration | 1-20ms | 3-20ms |
| Pulse Type | Single, multiple | Single, multiple |
| Electrical<br>Requirements | 100-240 V, 50-60 Hz | 220V±20V, 50Hz or<br>110V±20V, 60Hz, 20A |
| Weight | 45.55kg | 23kg |
| Dimensions<br>W x H x D | System console - 580 x 980<br>x 580 mm | 440 x 500 x 350 mm |
| Cooling | Sapphire | Sapphire |
| Cooling<br>Method | Continuous contact cooling | Continuous contact<br>cooling |
| Device<br>clasification | II: 21 CFR 878.4810 | II: 21 CFR 878.4810 |
| Product Code | ONF | ONF |
| Standards | IEC 60601-1, IEC 60601-1-<br>2, ISO 10993-5, ISO 10993-<br>10, ISI 14971, IEC 62304 | IEC 60601-1, IEC<br>60601-1-2 |

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image shows a logo with the letters B, T, and L. The letters are inside of three diamond shapes that are connected to each other. The logo is blue and the background is white. The logo is simple and modern.

### Substantial Equivalence

Based upon the intended use and technical information provided in this pre-market notification, the Exilite device has been shown to be substantially equivalent to currently marketed predicate devices.

### Conclusion

Based on the aforementioned information, the Exilite is safe and effective and substantially equivalent to the identified predicate devices.